Haynes Boone Advises Efemoral Medical in Series A1 Funding for New Innovation in Arterial Disease Treatment
January 24, 2023
January 24, 2023
DALLAS, Texas, Jan. 24 -- Haynes and Boone, a law firm, issued the following news release:
Haynes and Boone, LLP Attorney Gabor Szecsi represented Efemoral Medical, developer of advanced interventional bioresorbable therapies, in the closing of its $4.9M preferred Series A1 round.
The financing closed on Jan. 17, 2023. Supported by existing investors as well as an experienced cohort of new investors, the proceeds will further Efemoral's device development and expan . . .
Haynes and Boone, LLP Attorney Gabor Szecsi represented Efemoral Medical, developer of advanced interventional bioresorbable therapies, in the closing of its $4.9M preferred Series A1 round.
The financing closed on Jan. 17, 2023. Supported by existing investors as well as an experienced cohort of new investors, the proceeds will further Efemoral's device development and expan . . .